Related Experiment Video
Updated: Jul 16, 2026
08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsy
Jacques J Laschet1, Irène Kurcewicz, Frédéric Minier
1Institut National de la Santé et de la Recherche Médicale, Unité 573, F-75014 Paris, France. jacques.laschet@broca.inserm.fr
Summary
Epileptogenic human brain tissue shows impaired GABA(A) receptor phosphorylation, leading to unstable GABAergic inhibition. This dysfunction, linked to ATP production, may drive seizures and suggests new therapeutic targets for epilepsy.
Area of Science:
- Neuroscience
- Epilepsy Pathophysiology
- Molecular Neuroscience
Background:
- GABAergic neurotransmission is crucial for brain function, and its reduction is implicated in epilepsy.
- Previous studies suggested a link between GABAergic inhibition and epilepsy, but direct evidence in human tissue was limited.
- The glycolytic enzyme GAPDH's role in GABA(A) receptor phosphorylation was previously established as vital for receptor function.
Purpose of the Study:
- To investigate the functional lability of GABAergic inhibition in human epileptogenic neocortex.
- To determine if deficiencies in GABA(A) receptor endogenous phosphorylation contribute to epilepsy.
- To explore the relationship between GABAergic dysfunction, ATP metabolism, and regional cerebral glucose hypometabolism in epilepsy.
Main Methods:
- Analysis of human epileptogenic and nonepileptogenic neocortex tissue obtained during surgery.
- Measurement of GABA(A) receptor endogenous phosphorylation in isolated neurons.
- Assessment of GABAergic current lability using electrophysiological techniques.
- Quantification of GABA(A) receptor alpha1-subunits via photoaffinity labeling.
Main Results:
- Human epileptogenic cortex exhibits an intrinsic deficiency in GABA(A) receptor endogenous phosphorylation compared to non-epileptogenic tissue.
- This deficiency results in increased functional lability of GABAergic currents in neurons from epileptogenic tissue.
- The observed defect was not due to a reduced number of GABA(A) receptor alpha1-subunits.
- Maintaining receptor phosphorylation stabilized GABA(A) receptor responses in epileptogenic cortex.
Conclusions:
- A deficiency in GABA(A) receptor endogenous phosphorylation increases the functional lability of GABAergic inhibition in human epileptogenic cortex.
- This transient GABAergic disinhibition can promote seizure initiation and propagation.
- The findings suggest a link between impaired GABAergic mechanisms, dependent on local ATP, and the regional cerebral glucose hypometabolism seen in partial epilepsy.
- These insights open avenues for novel therapeutic strategies targeting GABAergic function in epilepsy.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...